Immunoglobulin D plasmacytoma carrying aberrant expression of CD33 associated with aggressive visceral involvement

被引：0
|
作者：
Suzuki, M [1 ]
Ohashi, K [1 ]
Sakamaki, H [1 ]
机构：
[1] Tokyo Metropolitan Komagome Hosp, Div Hematol, Bunkyo Ku, Tokyo 1138677, Japan
来源：
HAEMATOLOGICA | 2001年 / 86卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：895 / 895
页数：1
相关论文
共 19 条
  • [1] Aberrant expression of CD33 is associated with poor prognosis in patients with multiple myeloma and tumor progression
    Lee, Ki Hong
    Seo, Hee Seoung
    Sohn, Ji Yeon
    Lee, Eunyoung
    Lee, Hyewon
    Eom, Hyeon-Seok
    Kong, Sun-Young
    [J]. CANCER RESEARCH, 2016, 76
  • [2] CD33 SNP Genotype and Splice Variation Are Associated with CD33 Cell Surface Expression and SGN-CD33A Pharmacokinetics
    Tarlock, Katherine
    Wang, Zixing
    Rohm, Rory
    Biechele, Travis
    Ries, Rhonda E.
    Hylkema, Tiffany
    Lamba, Jatinder K.
    Means, Gary D.
    Thurman, Robert
    Arthur, Bill
    Meshinchi, Soheil
    [J]. BLOOD, 2018, 132
  • [3] Biclonal light chain gammopathy with aberrant CD33 expression in secondary plasma cell leukemia
    Gentry, Michael
    Pettenati, Mark
    Pang, Changlee S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (10): : 2224 - 2229
  • [4] Indolent T-lymphoblastic Proliferation With Disseminated Multinodal Involvement and Partial CD33 Expression
    Ohgami, Robert S.
    Sendamarai, Anoop K.
    Atwater, Susan K.
    Liedtke, Michaela
    Fleming, Mark D.
    Natkunam, Yasodha
    Warnke, Roger A.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (09) : 1298 - 1304
  • [5] P-GLYCOPROTEIN POSITIVE PHENOTYPE IS ASSOCIATED WITH CHANGES IN CD33 AND NESTIN EXPRESSION
    Imrichova, D.
    Guzyova, M.
    Seres, M.
    Messingerova, L.
    Bohacova, V.
    Sulova, Z.
    Breier, A.
    [J]. LEUKEMIA RESEARCH, 2017, 55 : S133 - S134
  • [6] EXPRESSION AND FUNCTION OF THE LATE-ONSET ALZHEIMER DISEASE ASSOCIATED CD33 IN HUMAN MICROGLIA
    Mathews, M. A.
    Grobe-Einsler, M.
    Roy, K.
    Neumann, H.
    [J]. GLIA, 2013, 61 : S84 - S85
  • [7] High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation
    De Propris, Maria Stefania
    Raponi, Sara
    Diverio, Daniela
    Milani, Maria Laura
    Meloni, Giovanna
    Falini, Brunangelo
    Foa, Robin
    Guarini, Anna
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (10): : 1548 - 1551
  • [8] Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells
    Garnache-Ottou, F
    Chaperot, L
    Biichle, S
    Ferrand, C
    Remy-Martin, JP
    Deconinck, E
    de Tailly, PD
    Bulabois, B
    Poulet, J
    Kuhlein, E
    Jacob, MC
    Salaun, W
    Arock, M
    Drenou, B
    Schillinger, F
    Seilles, E
    Tiberghien, P
    Bensa, JC
    Plumas, J
    Saas, P
    [J]. BLOOD, 2005, 105 (03) : 1256 - 1264
  • [9] Specific induction of CD33 expression by E2A–HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor
    K Akahane
    T Inukai
    T Inaba
    H Kurosawa
    A T Look
    N Kiyokawa
    J Fujimoto
    H Goto
    M Endo
    X Zhang
    K Hirose
    I Kuroda
    H Honna
    K Kagami
    K Goi
    S Nakazawa
    K Sugita
    [J]. Leukemia, 2010, 24 : 865 - 869
  • [10] Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor
    Akahane, K.
    Inukai, T.
    Inaba, T.
    Kurosawa, H.
    Look, A. T.
    Kiyokawa, N.
    Fujimoto, J.
    Goto, H.
    Endo, M.
    Zhang, X.
    Hirose, K.
    Kuroda, I.
    Honna, H.
    Kagami, K.
    Goi, K.
    Nakazawa, S.
    Sugita, K.
    [J]. LEUKEMIA, 2010, 24 (04) : 865 - 869
12